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Edited by Michael R. BubbAbstract The presynaptic P2X7 receptor (P2X7R) plays an
important role in the modulation of transmitter release. We re-
cently demonstrated that, in nerve terminals of the adult rat cere-
bral cortex, P2X7R activation induced Ca
2+-dependent vesicular
glutamate release and signiﬁcant Ca2+-independent glutamate
eﬄux through the P2X7R itself. In the present study, we investi-
gated the eﬀect of the new selective P2X7R competitive antago-
nist 3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methyl pyridine
(A-438079) on cerebrocortical terminal intracellular calcium
(intrasynaptosomal calcium concentration; [Ca2+]i) signals and
glutamate release, and evaluated whether P2X7R immunoreac-
tivity was consistent with these functional tests. A-438079 inhib-
ited functional responses. P2X7R immunoreactivity was found in
about 45% of cerebrocortical terminals, including glutamatergic
and non-glutamatergic terminals. This percentage was similar to
that of synaptosomes showing P2X7R-mediated [Ca
2+]i signals.
These ﬁndings provide compelling evidence of functional presyn-
aptic P2X7R in cortical nerve terminals.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The P2X7 receptor (P2X7R) is a non-selective cation channel
activated by extracellular ATP. It is able to switch to a so-
called pore conformation that is permeable to large organic
molecules up to 900 Da, leading to lysis and cell death [1]. It
has been shown to be expressed in immune cells and epithelia
as an immunomodulatory receptor [1,2]. However, a growing
amount of evidence indicates that the P2X7R participates inAbbreviations: A-438079, 3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-y
methyl pyridine; BzATP, 30-O-(4-benzoyl)benzoyl ATP; [Ca2+
intrasynaptosomal calcium concentration; HEK293, human embr
onic kidney cell line 293; P2X7-GFP, P2X7-green ﬂuorescent protei
VGLUT1, vesicular glutamate transporter 1; WGA, wheat ger
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ieties. Pudistinct neuronal, astroglial and microglial functions associ-
ated with the modulation of synaptic neurotransmission, and
that it is a potential target site in disorders of the nervous sys-
tem [3–5]. We recently studied rat cerebrocortical synapto-
somes, which constitute a useful model for the investigation
of functional proteins at the presynaptic level; our ﬁndings
suggested that the P2X7R plays a signiﬁcant role in ATP-
evoked glutamate eﬄux, which involves both Ca2+-dependent
vesicular release and Ca2+-independent eﬄux through the
P2X7R itself [6]. Although the immunoreactive P2X7 subunit
has frequently been found on central and peripheral neurones
[7–10], including rat cerebrocortical nerve terminals [11,12],
the reliability of P2X7 antibody testing has been questioned
[13,14]. Indeed, midbrain and cerebellar granule neurones in
P2X7R knockout mice seem to express a less eﬃcient ‘‘P2X7-
like’’ receptor which is recognized by commercial antibodies
and exhibits some functional properties similar to those of
the genuine P2X7R [15,16]. However, on merging electrophys-
iological, molecular and microﬂuorometric assays, or pharma-
cological and immunocytochemical characterisations, other
authors have provided compelling evidence of the existence
of a genuine P2X7R on diﬀerent types of neurones [9–11,17].
The aim of the present study was to increase our knowledge
of the P2X7 receptor in synaptosomes of adult rat cerebral cor-
tex by using diﬀerent techniques. We explored the relationship
between P2X7R immunoreactivity and functional responses
such as calcium (intrasynaptosomal calcium concentration;
[Ca2+]i) increase and glutamate release evoked by the potent
P2X7R agonist 3
0-O-(4-benzoyl)benzoyl ATP (BzATP). In
addition, we evaluated whether these P2X7R-mediated
functional activities were inhibited by the selective antagonist
3-(5-(2,3-dichlorophenyl)-1H-tetrazol-1-yl)methyl pyridine
(A-438079), a new potential tool for identifying the presence
of P2X7R in the brain [18–20].2. Materials and methods
2.1. Animals
Adult male Sprague Dawley rats (200–250 g) were housed at con-
stant temperature (22 ± 1 C) and humidity under a regular light-dark
schedule (light 7 a.m.–7 p.m.). Food and water were freely available.
Experimental procedures were carried out in accordance with Euro-
pean legislation (European Communities Directive of 24 November
1986, 86/609/EEC). Every eﬀort was made to minimize the number
of animals used and to reduce suﬀering.blished by Elsevier B.V. All rights reserved.
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After decapitation, the cerebral cortex was rapidly removed and
placed in ice-cold medium, and nerve terminals (puriﬁed synapto-
somes) were prepared on a discontinuous Percoll gradient, as previ-
ously reported [6,21]. Protein determinations were carried out
according to Bradford et al. [22]. For release experiments, synapto-
somes were suspended in standard medium (mM): NaCl 135; KCl
2.4; MgSO4 1.2; CaCl2 1.2; KH2PO4 1.2; NaHCO3 5 with glucose
10; pH 7.4. For immunoﬂuorescence confocal microscopy or [Ca2+]i
measurement, synaptosomal pellets containing 2 mg proteins were re-
suspended in 1 ml HEPES medium (mM): NaCl 128; KCl 2.4; MgSO4
1.2; KH2PO4 1.2; CaCl2 1.0; HEPES 10 with glucose 10; pH 7.4. A ali-
quot (15 ll) of suspended synaptosoms was deposited onto 20-mm
glass coverslips coated with Cell-Tack (BD Biosciences) and centri-
fuged at 3000 rpm (3 min.).2.3. HEK293 cells: cultures and stable transfection
Cultures of the human embryonic kidney cell line 293 (HEK293)
were maintained in Dulbeccos Modiﬁed Eagles Medium/Nutrient
Mixture F-12 Ham, supplemented with 10% foetal bovine serum and
gentamicin/glutamine (5 mg/ml and 200 mM, respectively) in a humid-
iﬁed incubator at 37 C in a 5% CO2-enriched atmosphere. HEK293
cells were stably transfected with the plasmid containing the full-length
rat P2X7-green ﬂuorescent protein (P2X7-GFP) cDNA in pcDNA3, as
previously described [6,23].
2.4. Immunoﬂuorescence confocal microscopy
Synaptosomes or HEK293 cells were ﬁxed with 2% paraformalde-
hyde, permeabilized with 0.05% Triton X-100 (5 min.) and incubated
for 30 min. with primary antibodies diluted in phosphate buﬀer saline
(PBS) containing 3% albumin. The following antibodies were used:
mouse anti-syntaxin1 (1:1000; Chemicon International), guinea pig
anti-vesicular glutamate transporter 1 (VGLUT1; 1:1000; Chemicon
International) and anti-extracellular epitope (aminoacids 136-152) of
P2X7 receptor (1:500; Alomone Labs). After washing with PBS, the
preparations were incubated (30 min) with Alexa Fluor 488 or 567 sec-
ondary antibody conjugates (1:500; Molecular Probes) in PBS contain-
ing 0.5% albumin. Alexa 567-conjugated wheat germ agglutinin
(WGA; 1:1000; Molecular Probes) was used to visualize nerve termi-
nals [26]. Fluorescence images were collected by means of an MRC-
1024 confocal microscope (Bio-Rad, Hercules, CA, USA). Spatial
co-localization was analyzed through two-dimensional correlation
cytoﬂuorograms obtained by means of macro routines integrated as
plug-ins in Laser Pix software (Bio-Rad). Red and green labels were
regarded as co-localised in the same pixel if their respective intensities
(0–255, eight bit) were strictly higher than the threshold of their chan-
nels, as determined by analyzing the color histograms. Data were col-
lected from 9–12 ﬁelds from at least three diﬀerent synaptosomal
preparations, and are expressed as mean ± S.E.M.2.5. Synaptosome superfusion experiments
After incubation with [3H]D-aspartate (0.03 lmol/L; 15 min), synap-
tosomes were superfused (0.5 mL/min) in parallel superfusion cham-
bers at 37 C with HEPES medium; tritium eﬄux in each fraction
was calculated as a percentage of the total tritium present at the onset
of the fraction considered (fractional release); the percent variation in
fractional release, with respect to the basal control value, was evalu-
ated in each fraction [6]. The drug-evoked tritium eﬄux was measured
by subtracting the areas under the curves of the percent variations in
tritium fractional release in control chambers from that seen in drug-
treated chambers; in each experiment, at least one chamber was used
as a control for each condition.2.6. Calcium imaging in single synaptic terminals
Intrasynaptosomal [Ca2+]i was measured by the FURA-2AMmicro-
ﬂuorimetric technique on single-glued terminals. Synaptosomes adher-
ing to coverslips were loaded with 5 lM FURA-2AM (45 min at
37 C) and then mounted in a microperfusion chamber on the stage
of a Nikon TE200 inverted ﬂuorescence microscope equipped with a
dual-excitation ﬂuorimetric Ca2+ imaging system (Hamamatsu). The
ratio F340/F380 was used to indicate the changes in [Ca2+]i from se-
lected regions of interest (ROI) covering a single synaptic terminal.
Experiments were performed as previously described [6,23].2.7. Western blotting
HEK293 stably expressing rat GFP-tagged P2X7 in C-termini, na-
tive cells and synaptosomal pellets were crumbled, and the samples
(10 mg) were separated by SDS–PAGE (10%), electrophoretically
transferred to a polyvinylidene diﬂuoride (Immobilon-P PVDF; Milli-
pore Corporation) membrane blocked in 5% dry fat milk in 50 mM
Tris, 150 mM NaCl, and hybridised with the anti-extracellular epitope
of P2X7R (1:500, Alomone Labs) antibody. All the salts, the protease
inhibitor cocktail and the molecular mass marker used (wide molecular
weight range) were obtained from Sigma.3. Results
The eﬀects of the potent P2X7R agonist, BzATP, on intra-
synaptosomal calcium levels [Ca2+]i and on [
3H]D-aspartate ef-
ﬂux were studied simultaneously in sister preparations of
freshly isolated adult rat cortical synaptosomes.
The Ca2+ imaging system was used in single cortical synap-
tosomes, and [Ca2+]i was expressed as F340/F380 ratio (see
Fig. 1A). In response to 100 lM BzATP, we identiﬁed a
[Ca2+]i increase in about 45% of reactive synaptosomes tested
by means of a depolarising event (35 mM K+) (n = 270 deter-
minations from 16 independent preparations; Fig. 1B). To
conﬁrm the contribution of P2X7R to the BzATP-induced
[Ca2+]i increase, we used 3 lM of A-438079, a recently discov-
ered selective P2X7 antagonist [26]. In the presence of A-
438079, the [Ca2+]i increase was signiﬁcantly blunted (n = 65
determinations from four independent preparations; Fig. 1C).
The eﬀect of A-438079 on BzATP-evoked glutamate release
was tested by measuring tritium eﬄux from puriﬁed synapto-
somes pre-labeled with [3H]D-aspartate. The behavior of
endogenous glutamate was indistinguishable from that of tri-
tium after labeling with [3H]D-aspartate, which justiﬁed the
use of [3H]D-aspartate. The fractional basal tritium outﬂow
amounted to 0.28 ± 0.03%/min (n = 3); BzATP (100 lM)-
evoked tritium release was inhibited by the selective P2X7R
antagonist A-438079 (3 lM; Fig. 1D). Addition of A-438079
at the concentration used did not aﬀect basal tritium eﬄux
(data not shown). These results unequivocally conﬁrm the
involvement of P2X7 in synaptosomal glutamate release, as al-
ready demonstrated in our previous study [6].
We carried out immunocytochemistry and western blotting
to identify P2X7R expression in cortical synaptosomal termi-
nals. To demonstrate the eﬃcacy of the extracellular anti-
P2X7 antibody, we immunostained HEK293 cells stably
expressing rat P2X7R-GFP (Fig. 2A–C). P2X7 immunostain-
ing revealed evident cell-surface P2X7R expression, which
completely merged in GFP ﬂuorescence. Total protein extracts
from synaptosomes and HEK293 cells (native or transfected
with rat P2X7R) were probed with the anti-P2X7 antibody;
western blot analysis revealed that native HEK293 cells did
not show immunostaining in synaptosomal preparations. By
contrast, the antibody displayed a distinct band of 70 kDa
corresponding to the rat P2X7 subunit, while the 95 kDa
band depicted in transfected HEK293 cells had the expected
molecular weight of the P2X7-GFP protein complex (Fig. 2D).
Syntaxin1 was used as a marker for our puriﬁed cerebrocor-
tical synaptosomal preparations, even though it has also been
seen to label cerebrocortical astrocytes in culture [24] and glio-
somes obtained from adult rat brain [25]. However, in our pre-
vious study puriﬁed synaptosomes were labeled with anti-
synaptophysin antibody, a marker of the synaptic terminal,
and were negative for the glial marker GFAP (glial ﬁbrillary
1
2
3 4
5
6
7
8
9
100 100 BzATP
3 A-438079
0
50
100
150
200
250
300
[3 H
]D
-as
pa
rta
te 
e
ffl
ux
 (%
 va
ria
tio
n)
BzATP
BzATP (μM)
A-438079
100 100
3
10
11
0.00
0.01
0.02
0.03
Δ 
F3
40
/F
38
0
8 μm
%
 o
f r
es
po
nd
in
g 
pa
rti
cle
s
0
20
40
60
80
100
100 
*
*
Drug concentration (μM)Drug concentration (μM)
35 KCl (mM)
Fig. 1. Functional evidence of the presence of presynaptic A-438079-sensitive P2X7R on adult rat cerebrocortical nerve terminals. (A) Fluorescence
image showing FURA-2AM loaded synaptosomes. The regions of interest (ROI) are represented by circles. Scale bar = 8 lm. (B) Bar graph
reporting the percentage of single synaptosomes responding to 100 lM BzATP and 35 mM K+. (C) Single synaptosome [Ca2+]i rose above basal
levels (expressed as D F340/F380 ratio) in response to 100 lM BzATP in the absence or presence of the antagonist A-438079. Data are
means ± S.E.M. of 65 determinations from 4 independent experiments. (D) Antagonism of BzATP-evoked [3H]D-aspartate eﬄux by 3 lMA-438079
from superfused cerebrocortical synaptosomes. Bars represent percent increase in tritium in the presence of the drugs. BzATP was added for 120 sec
during superfusion; A-438079 was added 8 min before the agonist; data are means ± S.E.M. of three independent experiments in triplicate. *P < 0.01
when compared to BzATP alone.
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Fig. 2. Anti-P2X7 antibody recognized P2X7R in synaptosomes and in transfected HEK cells. Confocal images from HEK293 cells stably expressing
P2X7R-GFP: immunoﬂuorescence for GFP (A), for P2X7R antibody (B) and merge image (C). (D) Western blot analysis: total protein extracts from
HEK293 cells expressing P2X7R-GFP, native cells and synaptosomal preparations were immunoblotted with the antibody anti-P2X7R. A band at
95 kDa and a band at 70 kDa were observed in transfected HEK cells and synaptosomes, respectively.
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godendrocyte marker RIP, indicating the absence of non-neu-
ronal contamination in our preparations [6].
Immunoﬂuorescence confocal microscopy experiments
showed that 66 ± 1.5% of rat cerebrocortical synaptosomes,
which were positive for the presynaptic marker syntaxin1, were
immunoreactive for VGLUT1 (Fig. 3A–D); 37 ± 3.7% of the
VGLUT1-positive synaptosomes were also stained by the
anti-P2X7 receptor antibody (Fig. 3E–H). VGLUT1-positive
synaptosomes accounted for 55 ± 2.5% of the total number
of P2X7-positive synaptosomes. Interestingly, the P2X7 anti-
body also labeled VGLUT1-negative synaptosomes (Fig. 3E–
H). Collectively, these data indicate the presence of P2X7R
immunoreactivity in a sub-population amounting to about45% of synaptosomes not restricted to glutamate-releasing
nerve terminals (see illustration in Fig. 3I).
Interestingly, analysis of co-localization of P2X7 immunore-
activity and WGA, a membrane glycosylated protein marker
used for nerve terminal identiﬁcation [26], showed a non-uni-
form receptor distribution on the external membrane of synap-
tosomes (Fig. 4A–D).4. Discussion
The present study conﬁrms the functional presence of the
P2X7R in presynaptic terminals from adult rat cortical neuro-
nes. The results add to our recent report, which demonstrated
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Fig. 4. Co-localization of P2X7R with WGA in single synaptosomes: the images represent WGA (A) and anti-P2X7 (B); merge image (C). (D)
Overlay plot of ﬂuorescence intensity proﬁle along the white bar. Note the non-uniform P2X7R distribution on the synaptosomal membrane.
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mate release [6].
In this study, the recently discovered speciﬁc P2X7R antag-
onist A-438079 induced a signiﬁcant reduction in P2X7R-med-
iated Ca2+ responses and [3H]D-aspartate-release, indicating
for the ﬁrst time the eﬃcacy of this drug in the brain. The com-
pound is reported to be essentially devoid of activity on other
P2 receptors and to show little or no activity on a wide array of
other cell-surface receptors and ion channels [19]. It has re-
cently been demonstrated that this antagonist potently blocks
both P2X7R-mediated ionic currents recorded in vivo in spinal
neuronal subtypes [20] and rat or human non-neuronal
P2X7R-induced [Ca
2+]i increase [18,19]. As this drug has never
been used on P2X7-like protein in knockout mice, the eﬃcacy
of the antagonist does not exclude the possible masked pres-ence of P2X7-like protein in our native preparation. It is there-
fore very important to check the potency of this compound on
the P2X7-like receptor in knockout mice [15,16].
We found that a signiﬁcant fraction of nerve terminals
(about 45%) were stained by the anti-P2X7 subunit antibody.
This ﬁnding is in line with observations made on other rodent
brain areas (rat and mouse midbrain: 52% and 32%, respec-
tively, and rat cerebellum: 60%) [15,27,28]. Notably, the per-
centage of immunoreactive terminals was comparable to that
of synaptosomes showing P2X7-mediated Ca
2+ responses.
By using a quantitative immunohistochemical study, we
demonstrated that about 66% of (syntaxin1-positive) cerebro-
cortical nerve terminals were glutamatergic, as indicated by
expression of VGLUT1, and that a sub-population (about
37%) of the glutamatergic terminals was immunoreactive to
3952 S. Alloisio et al. / FEBS Letters 582 (2008) 3948–3953P2X7 antibodies. A sub-population of non-glutamatergic nerve
terminals was also labeled by the P2X7 antibody, the
VGLUT1-positive terminals representing only 55% of the
P2X7-positive synaptosomes. P2X7 immunoreactivity on
VGLUT1-negative terminals can most likely be assigned to
non-glutamatergic terminals, as reported by Atkinson et al.
[12]. Indeed, in rat cerebral cortex, P2X7R co-localised only
with VGLUT1 transporter on glutamatergic nerve terminals,
whereas P2X7-immunoreactive and VGLUT2-immunoreactive
varicosities formed separate populations.
Confocal immunolocalization on single synaptic terminals
conﬁrmed the presence of P2X7R on synaptosomes. The co-
localization of P2X7 immunoreactivity and the neuronal
membrane marker WGA revealed a non-uniform receptor dis-
tribution on the synaptosomal membrane: such a distribution
pattern is compatible with the hypothesis that P2X7R could be
localized near the active zones, as reported in cerebellar gran-
ules [29], and appears consistent with the involvement of
P2X7R in the control of synaptic vesicle traﬃcking.
In summary, the data reported in this study show a good
correlation between P2X7 immunoreactivity and functional
assays, which is strongly supported by the antagonism of
A-438079. Moreover, P2X7R expression is associated with
excitatory terminals (VGLUT1-positive), as well as the non-
glutamatergic sub-population of synaptosomes, indicating a
widespread presence of the receptor in the neocortex.
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